These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
355 related articles for article (PubMed ID: 31736949)
1. Haploidentical Stem Cell Transplantation in Children With Hematological Malignancies Using αβ Diaz MA; Zubicaray J; Molina B; Abad L; Castillo A; Sebastian E; Galvez E; Ruiz J; Vicario JL; Ramirez M; Sevilla J; González-Vicent M Front Immunol; 2019; 10():2504. PubMed ID: 31736949 [TBL] [Abstract][Full Text] [Related]
2. Prognostic factors and outcomes for pediatric patients receiving an haploidentical relative allogeneic transplant using CD3/CD19-depleted grafts. Diaz MA; Pérez-Martínez A; Herrero B; Deltoro N; Martinez I; Ramirez M; Abad L; Sevilla J; Merino E; Ruiz J; Vicario JL; Gonzalez-Vicent M Bone Marrow Transplant; 2016 Sep; 51(9):1211-6. PubMed ID: 27088380 [TBL] [Abstract][Full Text] [Related]
3. Reconstitution of T and NK cells after haploidentical hematopoietic cell transplantation using αβ T cell-depleted grafts and the clinical implication of γδ T cells. Park M; Im HJ; Lee YJ; Park N; Jang S; Kwon SW; Park CJ; Choi ES; Koh KN; Seo JJ Clin Transplant; 2018 Jan; 32(1):. PubMed ID: 29090489 [TBL] [Abstract][Full Text] [Related]
4. TcRαβ-depleted haploidentical transplantation results in adult acute leukemia patients. Kaynar L; Demir K; Turak EE; Öztürk ÇP; Zararsız G; Gönen ZB; Gökahmetoğlu S; Şıvgın S; Eser B; Köker Y; Solmaz M; Ünal A; Çetin M Hematology; 2017 Apr; 22(3):136-144. PubMed ID: 27724812 [TBL] [Abstract][Full Text] [Related]
5. Haploidentical Natural Killer Cells Infused before Allogeneic Stem Cell Transplantation for Myeloid Malignancies: A Phase I Trial. Lee DA; Denman CJ; Rondon G; Woodworth G; Chen J; Fisher T; Kaur I; Fernandez-Vina M; Cao K; Ciurea S; Shpall EJ; Champlin RE Biol Blood Marrow Transplant; 2016 Jul; 22(7):1290-1298. PubMed ID: 27090958 [TBL] [Abstract][Full Text] [Related]
6. Early Cytomegalovirus Reactivation and Expansion of CD56 Jang JE; Hwang DY; Chung H; Kim SJ; Eom JI; Jeung HK; Song J; Kim JS; Cheong JW; Min YH Biol Blood Marrow Transplant; 2019 Oct; 25(10):2070-2078. PubMed ID: 31212079 [TBL] [Abstract][Full Text] [Related]
7. Immune Modulation Properties of Zoledronic Acid on TcRγδ T-Lymphocytes After TcRαβ/CD19-Depleted Haploidentical Stem Cell Transplantation: An analysis on 46 Pediatric Patients Affected by Acute Leukemia. Merli P; Algeri M; Galaverna F; Milano GM; Bertaina V; Biagini S; Girolami E; Palumbo G; Sinibaldi M; Becilli M; Leone G; Boccieri E; Grapulin L; Gaspari S; Airoldi I; Strocchio L; Pagliara D; Locatelli F Front Immunol; 2020; 11():699. PubMed ID: 32477328 [TBL] [Abstract][Full Text] [Related]
8. CD56-enriched donor cell infusion after post-transplantation cyclophosphamide for haploidentical transplantation of advanced myeloid malignancies is associated with prompt reconstitution of mature natural killer cells and regulatory T cells with reduced incidence of acute graft versus host disease: A pilot study. Jaiswal SR; Zaman S; Nedunchezhian M; Chakrabarti A; Bhakuni P; Ahmed M; Sharma K; Rawat S; O'donnell P; Chakrabarti S Cytotherapy; 2017 Apr; 19(4):531-542. PubMed ID: 28131632 [TBL] [Abstract][Full Text] [Related]
10. Joint Modeling of Immune Reconstitution Post Haploidentical Stem Cell Transplantation in Pediatric Patients With Acute Leukemia Comparing CD34 Salzmann-Manrique E; Bremm M; Huenecke S; Stech M; Orth A; Eyrich M; Schulz A; Esser R; Klingebiel T; Bader P; Herrmann E; Koehl U Front Immunol; 2018; 9():1841. PubMed ID: 30154788 [TBL] [Abstract][Full Text] [Related]
11. Reconstitution of natural killer cell receptors influences natural killer activity and relapse rate after haploidentical transplantation of T- and B-cell depleted grafts in children. Pfeiffer MM; Feuchtinger T; Teltschik HM; Schumm M; Müller I; Handgretinger R; Lang P Haematologica; 2010 Aug; 95(8):1381-8. PubMed ID: 20145268 [TBL] [Abstract][Full Text] [Related]
12. Immune Reconstitution Following TCRαβ/CD19-Depleted Hematopoietic Cell Transplantation for Hematologic Malignancy in Pediatric Patients. Arnold DE; MacMath D; Seif AE; Heimall JR; Wang Y; Monos D; Grupp SA; Bunin NJ Transplant Cell Ther; 2021 Feb; 27(2):169.e1-169.e9. PubMed ID: 33830028 [TBL] [Abstract][Full Text] [Related]
13. Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3/CD19 depletion and reduced intensity conditioning: an update. Bethge WA; Faul C; Bornhäuser M; Stuhler G; Beelen DW; Lang P; Stelljes M; Vogel W; Hägele M; Handgretinger R; Kanz L Blood Cells Mol Dis; 2008; 40(1):13-9. PubMed ID: 17869547 [TBL] [Abstract][Full Text] [Related]
14. Haploidentical HSCT for hemoglobinopathies: improved outcomes with TCRαβ Gaziev J; Isgrò A; Sodani P; Paciaroni K; De Angelis G; Marziali M; Ribersani M; Alfieri C; Lanti A; Galluccio T; Adorno G; Andreani M Blood Adv; 2018 Feb; 2(3):263-270. PubMed ID: 29431621 [TBL] [Abstract][Full Text] [Related]
15. Allogeneic hematopoietic stem-cell transplantation from haploidentical donors using 'ex-vivo' T-cell depletion in pediatric patients with hematological malignancies: state of the art review. González-Vicent M; Díaz Perez MA Curr Opin Oncol; 2018 Nov; 30(6):396-401. PubMed ID: 30307414 [TBL] [Abstract][Full Text] [Related]